A 2.7-kb portion of the 5' flanking region of the murine glycoprotein alpha(IIB) gene is transcriptionally active in primitive hematopoietic progenitor cells

被引:45
作者
Tropel, P
Roullot, V
Vernet, M
Poujol, C
Pointu, H
Nurden, P
Marguerie, G
TronikLeRoux, D
机构
[1] CEA, DEPT BIOL MOL & STRUCT, LAB TRANSGENESE & DIFFERENCIAT CELLULAIRE, F-38054 GRENOBLE 9, FRANCE
[2] HOP CARDIOL, CNRS, UMR 5533, LAB HEMOBIOL, PESSAC, FRANCE
关键词
D O I
10.1182/blood.V90.8.2995
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The continuous generation of mature blood cells from primitive multipotent progenitor cells requires a highly complex series of cellular events that are still largely unknown. To examine the molecular events associated with the commitment of these hematopoietic progenitor cells to the megakaryocytic lineage, the alpha subunit of the platelet integrin alpha(IIb)beta(3) was used as marker. Despite an abundance of information regarding the role of this integrin in platelet adhesion and aggregation, the mechanisms that control the expression of the genes that code for these proteins are poorly understood and the earliest hematopoietic cell capable of expressing them has not been clearly identified. Thus, a strategy was developed to eradicate, using a conditional toxigene, all the hematopoietic cells capable of expressing the alpha(IIb) gene in mice. This was achieved by targeting the expression of the gene encoding the herpes simplex virus thymidine kinase (tk), specifically to these cell types, using a 2.7-kb fragment of the 5'-flanking region of the murine alpha(IIb) gene. Three transgenic lines having 1, 3, and 4 copies of the transgene, respectively were produced and analyzed. Administration of ganciclovir (GCV) to these mice induced a severe thrombocytopenia, which was due to the depletion of the entire megakaryocytic lineage, as shown by bone marrow (BM) culture and electron microscopy analysis. The time required to attain a severe thrombocytopenia was dependent on the level of the expression of the transgene and varied from 7 to 11 days. This condition was completely reversed when GCV treatment was discontinued. Progenitor cell assays showed that the alpha(IIb) promoter was active in primitive hematopoietic progenitor cells possessing myeloid, erythroid, and megakaryocytic potential and that the transcriptional activity of the promoter decreased progressively as differentiation proceeded towards the erythroid and myeloid lineages. (C) 1997 by The American Society of Hematology.
引用
收藏
页码:2995 / 3004
页数:10
相关论文
共 48 条
[21]  
Hoffman R, 1996, Stem Cells, V14 Suppl 1, P75
[22]   STUDIES ON THE MEGAKARYOCYTES OF A PATIENT WITH THE BERNARD-SOULIER SYNDROME [J].
HOURDILLE, P ;
PICO, M ;
JANDROTPERRUS, M ;
LACAZE, D ;
LOZANO, M ;
NURDEN, AT .
BRITISH JOURNAL OF HAEMATOLOGY, 1990, 76 (04) :521-530
[23]   PROMOTION OF MEGAKARYOCYTE PROGENITOR EXPANSION AND DIFFERENTIATION BY THE C-MPL LIGAND THROMBOPOIETIN [J].
KAUSHANSKY, K ;
LOK, S ;
HOLLY, RD ;
BROUDY, VC ;
LIN, N ;
BAILEY, MC ;
FORSTROM, JW ;
BUDDLE, MM ;
OORT, PJ ;
HAGEN, FS ;
ROTH, GJ ;
PAPAYANNOPOULOU, T ;
FOSTER, DC .
NATURE, 1994, 369 (6481) :568-571
[24]  
Kaushansky K, 1996, EXP HEMATOL, V24, P265
[25]   HUMAN MEGAKARYOCYTES .5. CHANGES IN THE PHENOTYPIC PROFILE OF DIFFERENTIATING MEGAKARYOCYTES [J].
LEVENE, RB ;
LAMAZIERE, JMD ;
BROXMEYER, HE ;
LU, L ;
RABELLINO, EM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1985, 161 (03) :457-474
[26]  
LEVIN J, 1994, BLOOD, V83, P3829
[27]  
LONG MW, 1981, BLOOD, V58, P1032
[28]   EXPRESSION OF AN ERYTHROID TRANSCRIPTION FACTOR IN MEGAKARYOCYTIC AND MAST-CELL LINEAGES [J].
MARTIN, DIK ;
ZON, LI ;
MUTTER, G ;
ORKIN, SH .
NATURE, 1990, 344 (6265) :444-447
[29]   LACK OF TRANSCRIPTION AND EXPRESSION OF THE ALPHA-IIB INTEGRIN IN HUMAN EARLY HEMATOPOIETIC STEM-CELLS [J].
MOLLA, A ;
ANDRIEUX, A ;
CHAPEL, A ;
SCHWEITZER, A ;
BERTHIER, R ;
MARGUERIE, G .
BRITISH JOURNAL OF HAEMATOLOGY, 1992, 82 (04) :635-639
[30]  
MOOLTEN FL, 1986, CANCER RES, V46, P5276